Graft characteristics infused in patients with or without CMV-R
| . | CMV-R . | P . | |
|---|---|---|---|
| No (n = 16) . | Yes (n = 10) . | ||
| CD34+/kg × 106 | 14.5 (11.9-18.9) | 16.1 (11.9-23.6) | .6 |
| CD3+/kg × 106 | 11.7 (6.7-17.8) | 13.8 (8.1-22.3) | .99 |
| TCR-αβ/kg × 106 | 0.01 (0.008-0.05) | 0.02 (0.01-0.04) | .95 |
| TCR-ϒδ/kg × 106 | 12.9 (9-16.3) | 12.7 (8.3-15.7) | .96 |
| NK+/kg × 106 | 30.6 (19.8-49.7) | 28.0 (17.1-41.8) | .64 |
| CD20+/kg × 106 | 0.01 (0.01-0.02) | 0.02 (0.01-0.04) | .25 |
| . | CMV-R . | P . | |
|---|---|---|---|
| No (n = 16) . | Yes (n = 10) . | ||
| CD34+/kg × 106 | 14.5 (11.9-18.9) | 16.1 (11.9-23.6) | .6 |
| CD3+/kg × 106 | 11.7 (6.7-17.8) | 13.8 (8.1-22.3) | .99 |
| TCR-αβ/kg × 106 | 0.01 (0.008-0.05) | 0.02 (0.01-0.04) | .95 |
| TCR-ϒδ/kg × 106 | 12.9 (9-16.3) | 12.7 (8.3-15.7) | .96 |
| NK+/kg × 106 | 30.6 (19.8-49.7) | 28.0 (17.1-41.8) | .64 |
| CD20+/kg × 106 | 0.01 (0.01-0.02) | 0.02 (0.01-0.04) | .25 |